Related Experiment Video
Updated: Jun 17, 2026
06:15
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
Novel adjuvants for B cell immune responses
Karin Loré1, Gunilla B Karlsson Hedestam
1Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Current Opinion in HIV and AIDS
|January 6, 2010
Summary
New adjuvants enhance B-cell responses to protein vaccines by engaging specific immune pathways. Understanding these interactions aids in designing potent vaccines against diseases like HIV-1.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Adjuvants are critical for enhancing vaccine efficacy, particularly for protein-based vaccines.
- Developing effective adjuvants that elicit robust B-cell responses remains a key challenge in vaccinology.
Purpose of the Study:
- To review recent advancements in adjuvant development, focusing on those that improve B-cell immunity.
- To discuss the mechanisms by which adjuvants interact with the immune system in the context of virus-based vaccines.
Main Methods:
- Review of established and novel experimental approaches in adjuvant research.
- Analysis of recent findings on adjuvant mechanisms of action and their impact on B-cell responses.
Main Results:
- Two new adjuvants approved; numerous others in development.
- Elucidation of adjuvant mechanisms, including aluminum hydroxide salts activating Nalp3 and B-cell activation via invariant natural killer T-cells.
- Characterization of Toll-like receptor ligand effects on B-cell differentiation and adjuvant properties of IPS-1-derived peptides.
Conclusions:
- Advances in understanding innate-adaptive immunity signaling pathways are crucial for designing improved adjuvants.
- Targeted adjuvant design can promote broad and potent B-cell responses for enhanced vaccine efficacy.
More Related Videos
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:40Cell-mediated Immune Responses
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...